Why the study?
The incidence of diabetes is growing and diabetics have an increased risk of atherosclerosis and diffuse CAD, prompting an assessment of revascularization treatment, management changes, and long-term survival in Iceland.
Does PCI compared to CABG improve long-term survival in patients with diabetes and coronary artery disease?
Cohort (n=1,485)
Yes
Does PCI compared to CABG improve long-term survival in patients with diabetes and coronary artery disease?
In a real-world Icelandic cohort of diabetic patients with coronary artery disease, the use of PCI increased significantly over a decade and demonstrated comparable long-term survival to CABG, despite differing baseline patient characteristics.
Answers are grounded in this paper and cite their sources.
Comparable survival with PCI versus CABG in diabetic CAD should not yet change practice; leaves open need for randomized confirmation.
BACKGROUND: The incidence of diabetes is growing, and diabetics have increased risk of atherosclerosis and diffuse coronary artery disease (CAD). Our aim was to assess the revascularization treatment of diabetics with CAD in Iceland from 2010-2020, changes in management and long-term survival of patients. METHODS: All patients in Iceland with diabetes and CAD on cardiac catheterization 2010-2020 were included in this retrospective, population-based study. We analyzed data from the SCAAR/SWEDEHEART database: patients' background information, findings of cardiac catheterization, planned treatment and results. The Kaplan-Meier method was used to estimate long-term survival and Cox-regression-analysis to adjust for predictor variables. RESULTS: Of 1905 cases (1485 patients), 1230 (65%) underwent PCI, 274 (14%) CABG and 401 (21%) had medical therapy only. The age distribution differed: The PCI group had the widest age bracket, the CABG group the narrowest, and the medical therapy group had the highest mean age. Most patients with STEMI or cardiogenic shock underwent PCI, while most patients with concomitant heart-valve disease underwent CABG. The proportion of patients undergoing CABG increased with more diffuse CAD. 41% of patients with left main- and three-vessel disease underwent CABG while only 2% of those with single-vessel disease. From 2010-2020 the proportion of patients that underwent PCI increased from 49% to 72%. There was no difference in survival between the PCI and CABG groups (p=1.00). CONCLUSION: Three quarters of patients with diabetes and obstructive CAD are now treated with PCI. The PCI and CABG groups had overall equal survival but the groups had different characteristics.
No takes yet. Share an insight, caveat, or question.
Kristjánsdóttir et al. (2022) conducted a cohort in Diabetes mellitus and coronary artery disease (n=1,485). Percutaneous coronary intervention (PCI) vs. Coronary artery bypass grafting (CABG) was evaluated on Overall survival (HR 0.86, 95% CI 0.58-1.26, p=1.00).
Synapse has enriched 10 related papers. Consider them for comparative context: